Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB) Revenue (2024 - 2025)

Nuvation Bio (NUVB) has disclosed Revenue for 2 consecutive years, with $41.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Revenue rose 633.06% to $41.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $62.9 million, a 698.96% increase, with the full-year FY2025 number at $62.9 million, up 698.96% from a year prior.
  • Revenue was $41.9 million for Q4 2025 at Nuvation Bio, up from $13.1 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $41.9 million in Q4 2025 to a low of $727000.0 in Q3 2024.